Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_assertion type Assertion NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_head.
- NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_provenance.
- NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_assertion evidence source_evidence_literature NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_provenance.
- NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_assertion SIO_000772 10368524 NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_provenance.
- NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_assertion wasDerivedFrom befree-2016 NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_provenance.
- NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_assertion wasGeneratedBy ECO_0000203 NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_provenance.